What is sclerodactyly?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What is Sclerodactyly?

Sclerodactyly is thickening and tightening of the skin of the fingers and hands, characterized by shiny, tight, hardened skin that restricts finger movement and is a hallmark clinical feature of systemic sclerosis (scleroderma). 1

Clinical Characteristics

Sclerodactyly presents as:

  • Skin thickening and hardening that primarily affects the fingers, making the skin appear shiny, tight, and bound down to underlying structures 1
  • Progressive flexion contractures of the fingers that develop over time, limiting hand function 2, 3
  • Atrophic, dry skin on the dorsal (back) surface of the hands in more advanced cases 2
  • Tapered, sausage-like appearance of the fingers due to the sclerotic changes 3

Diagnostic Significance

Sclerodactyly is a key diagnostic finding in systemic sclerosis and helps distinguish it from other conditions: 1, 4

  • According to the 2013 ACR/EULAR Classification Criteria, skin thickening of the fingers extending proximal to the metacarpophalangeal (MCP) joints is sufficient alone to classify a patient as having systemic sclerosis 4
  • When sclerodactyly is observed during physical examination alongside telangiectasia and digital ulceration, it strongly suggests scleroderma as the underlying diagnosis 1
  • The finding helps differentiate systemic sclerosis from other sclerodermoid disorders like scleromyxedema, scleredema, or nephrogenic systemic fibrosis 4

Associated Clinical Features

Sclerodactyly rarely occurs in isolation and is typically accompanied by: 1, 5

  • Raynaud phenomenon (episodic color changes in fingers triggered by cold or stress) in nearly all patients 1, 5
  • Digital ulcers occurring in approximately 50% of patients with systemic sclerosis 1, 5
  • Telangiectasia (visible dilated blood vessels) on hands and face 1, 6
  • Calcinosis (calcium deposits in soft tissues) 3, 6

Pathophysiology

The underlying mechanism involves: 4, 3

  • Microvascular alterations affecting blood flow to the fingers 4
  • Chronic inflammation in early stages 4
  • Progressive fibrosis with excessive collagen deposition in the dermis and subcutaneous tissues in advanced stages 4, 3
  • Poorly vascularized tissue with deficient soft-tissue envelopes, which increases susceptibility to wound healing complications 3

Clinical Context and Prognosis

Sclerodactyly indicates systemic involvement and warrants comprehensive screening: 1, 5

  • Patients with sclerodactyly require screening for interstitial lung disease (ILD) and pulmonary arterial hypertension (PAH) using pulmonary function tests, high-resolution CT, and echocardiography 1, 5
  • Regular blood pressure monitoring is essential, especially in patients with anti-RNA polymerase III antibodies, to detect scleroderma renal crisis early 1, 5
  • The presence of sclerodactyly typically indicates established systemic sclerosis rather than early or prescleroderma stages 1

Important Clinical Pitfall

Do not confuse sclerodactyly with diabetic sclerodactyly (diabetic cheiroarthropathy), which occurs in patients with long-standing diabetes mellitus and presents with similar skin thickening but has a different pathophysiology and does not involve the systemic features of scleroderma. 7 Histopathologic examination can differentiate these conditions when clinical distinction is unclear. 4, 7

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Hereditary sclerodactyly and syndactyly].

Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 1985

Research

Scleroderma of the Hand: Evaluation and Treatment.

The Journal of the American Academy of Orthopaedic Surgeons, 2020

Research

Scleroderma with an update about clinico-pathological correlation.

Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2018

Guideline

Management of CREST Syndrome

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Pathogenesis of telangiectasia in scleroderma.

Asian Pacific journal of allergy and immunology, 2000

Research

Scleredema and diabetic sclerodactyly.

Dermatology online journal, 2005

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.